150 related articles for article (PubMed ID: 38680618)
1. Co-relation of Portal Vein Tumour Thrombus Response With Survival Function Following Robotic Radiosurgery in Vascular Invasive Hepatocellular Carcinoma.
Dutta D; Yarlagadda S; Kalavagunta S; Nair H; Sasidharan A; Nimmya SK; Kannan R; George S; Edappattu A; Haridas NK; Jose WM; Keechilat P; Valsan A; Koshy A; Gopalakrishna R; Sadasivan S; Gopalakrishnan U; Balakrishnan D; Sudheer OV; Surendran S
J Clin Exp Hepatol; 2024; 14(5):101404. PubMed ID: 38680618
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study.
Dutta D; Tatineni T; Yarlagadda S; Gupte A; Reddy SK; Madhavan R; Nair H; Sasidharan A; Kannan R; Pottayil SG; Holla R; Sudhindran S
Indian J Gastroenterol; 2021 Aug; 40(4):389-401. PubMed ID: 34694581
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma.
Jun BG; Kim YD; Cheon GJ; Kim ES; Jwa E; Kim SG; Kim YS; Kim BS; Jeong SW; Jang JY; Lee SH; Kim HS
Korean J Intern Med; 2018 Nov; 33(6):1093-1102. PubMed ID: 28844122
[TBL] [Abstract][Full Text] [Related]
5. Clinical Values and Markers of Radiation-Induced Liver Disease for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Stereotactic Body Radiotherapy.
Jia J; Sun J; Duan X; Li W
Front Oncol; 2021; 11():760090. PubMed ID: 34970485
[TBL] [Abstract][Full Text] [Related]
6. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
Velec M; Haddad CR; Craig T; Wang L; Lindsay P; Brierley J; Brade A; Ringash J; Wong R; Kim J; Dawson LA
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):939-946. PubMed ID: 28333016
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
[TBL] [Abstract][Full Text] [Related]
9. Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
Garin E; Rolland Y; Edeline J; Icard N; Lenoir L; Laffont S; Mesbah H; Breton M; Sulpice L; Boudjema K; Rohou T; Raoul JL; Clement B; Boucher E
J Nucl Med; 2015 Mar; 56(3):339-46. PubMed ID: 25678490
[TBL] [Abstract][Full Text] [Related]
10. Role of stereotactic body radiotherapy for inferior vena cava tumour thrombus in hepatocellular carcinoma.
Sharma D; Thaper D; Kamal R; Yadav HP
J Med Imaging Radiat Oncol; 2023 Jun; 67(4):444-449. PubMed ID: 37036106
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy.
Hasan S; Thai N; Uemura T; Kudithipudi V; Renz P; Abel S; Kirichenko AV
World J Gastrointest Surg; 2017 Dec; 9(12):256-263. PubMed ID: 29359031
[TBL] [Abstract][Full Text] [Related]
12.
Abouchaleh N; Gabr A; Ali R; Al Asadi A; Mora RA; Kallini JR; Mouli S; Riaz A; Lewandowski RJ; Salem R
J Nucl Med; 2018 Jul; 59(7):1042-1048. PubMed ID: 29217739
[TBL] [Abstract][Full Text] [Related]
13. High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma.
Jang WI; Kim MS; Bae SH; Cho CK; Yoo HJ; Seo YS; Kang JK; Kim SY; Lee DH; Han CJ; Kim J; Park SC; Kim SB; Cho EH; Kim YH
Radiat Oncol; 2013 Oct; 8():250. PubMed ID: 24160944
[TBL] [Abstract][Full Text] [Related]
14. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters.
Jung J; Yoon SM; Kim SY; Cho B; Park JH; Kim SS; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
Radiat Oncol; 2013 Oct; 8():249. PubMed ID: 24160910
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasion.
Munoz-Schuffenegger P; Barry A; Atenafu EG; Kim J; Brierley J; Ringash J; Brade A; Dinniwell R; Wong RKS; Cho C; Kim TK; Sapisochin G; Dawson LA
Radiother Oncol; 2021 Mar; 156():120-126. PubMed ID: 33285195
[TBL] [Abstract][Full Text] [Related]
16. Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05).
Bae SH; Park HC; Yoon WS; Yoon SM; Jung IH; Lee IJ; Kim JW; Seong J; Kim TH; Nam TK; Choi Y; Lee SY; Jang HS; Lee DS; Kim JH
Cancer Res Treat; 2019 Oct; 51(4):1589-1599. PubMed ID: 30971065
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy versus intensity-modulated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
Li LQ; Zhou Y; Huang Y; Liang P; Liang SX; Su TS
Hepatol Int; 2021 Jun; 15(3):630-641. PubMed ID: 33818714
[TBL] [Abstract][Full Text] [Related]
18. Role of palliative SBRT in barcelona clinic liver cancer-stage C hepatocellular carcinoma patients.
Sharma D; Thaper D; Kamal R; Yadav HP
Strahlenther Onkol; 2023 Sep; 199(9):838-846. PubMed ID: 36932236
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma.
Que J; Kuo HT; Lin LC; Lin KL; Lin CH; Lin YW; Yang CC
BMC Cancer; 2016 Jul; 16():451. PubMed ID: 27405814
[TBL] [Abstract][Full Text] [Related]
20. Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression.
Memon K; Kulik L; Lewandowski RJ; Mulcahy MF; Benson AB; Ganger D; Riaz A; Gupta R; Vouche M; Gates VL; Miller FH; Omary RA; Salem R
J Hepatol; 2013 Jan; 58(1):73-80. PubMed ID: 23000237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
